Leptin Is a Mucosecretagogue in Nasal Polyps
Yong-Dae Kim, MD, PhD (presenter); Hyun-Jae Woo, MD, PhD; Deok Hwan Chi, MD; Heung-Man Lee, MD, PhD OBJECTIVE: Leptin is a pleiotropic hormone that regulates food intake as well as metabolic and endocrine functions. Serum leptin levels have been reported to be increased in patients with allergic rhinitis and nasal polyposis; however, the explanation for this is unclear. We aimed to demonstrate the differential expression of leptin receptors in normal human nasal mucosa and nasal polyps, and to elucidate the effects of leptin on mucin gene expression in human nasal polyp epithelial cells. METHOD: Normal ethmoid sinus mucosa was obtained from 10 subjects and used as a control; nasal polyps were obtained from 10 patients. Leptin receptor expression was analyzed using RT-PCR and Western blot analysis. Leptin-induced ex-pression of major respiratory mucins (MUC5AC and MUC5B) in the human nasal polyp epithelial cells was determined using RT-PCR and ELISA. RESULTS: The leptin receptor expression was stronger in the nasal polyps than in the normal nasal mucosa. In human nasal polyp epithelial cells, leptin increased the expression of MUC5AC and MUC5B, in a dose-and time-dependent manner, at the gene and protein levels. Leptin-induced mucin expression was inhibited by the leptin receptor antagonist. CONCLUSION: The increased expression of leptin receptors in nasal polyps implies leptin has a certain role in nasal polyposis. In addition, leptin appears to induce the expression of MUC5AC and MUC5B through leptin receptors in the human nasal polyp epithelial cells.
Leukotriene1 and Glucocorticoid Receptor-␤ in Nasal Polyps
Kwang Hyun Kim (presenter); Chul Hee Lee, MD; Yang-Gi Min, MD, PhD; Doo Hee Han OBJECTIVE: The aim of this study was to analyze the expression of the cysteinyl leukotriene 1 receptor (CysLT1) receptor and glucocorticoid receptors (GRs) in nasal polyps, and evaluate the correlation between the expression of the CysLT1 receptor and GRs. METHOD: Nasal polyps were taken from 32 patients of chronic rhinosinusitis with nasal polyposis as study subjects. Samples of middle turbinate from 7 healthy subjects were used as controls. Specimens were immunohistochemically stained to quantify the CysLT1 receptor, GR-␣, and GR-␤ receptor in the unit area of the tissues. RESULTS: Numbers of the CysLT1 receptor positive cells were much increased in nasal polyps than in middle turbinate mucosa (281 67 vs 157 85 cells/mm2; Pϭ.01). There was no significant difference in the numbers of GR-␣ positive cells between nasal polyps and normal nasal mucosa. GR-␤ positive cells were increased in nasal polyps as compared to normal mucosa (36 8 vs 19 7 cells/mm2; Pϭ.03). There was a significant correlation between the expression of the CysLT1 receptor and GR-␤ in nasal polyps (Rϭ.525, Pϭ.04), whereas there was no significant correlation between the expression of the CysLT1 receptor and GR-␣ in nasal polyps. CONCLUSION: Our study shows that the CysLT1 receptor expression predominates on GR-␤ over-expressed polyps. This may provide a clue that the CysLT1 receptor antagonist can be beneficial for some nasal polyposis patients uncontrolled by steroids.
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